An Inpatient Advanced Care Practitioner-delivered Advance Care Planning Intervention for Older Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes APP SICP

What's the purpose of this trial?

This is a pilot study to assess the preliminary efficacy of an inpatient advanced care practitioner (APP)-delivered advance care planning intervention on outcomes in older patients with acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS).

This trial is currently open and accepting patients.

What will happen during the trial?

You may be able to join this trial if you:

The following criteria is a partial list of reasons why patients may be eligible to participate in this clinical trial. Further evaluation with a medical professional is required.

Inclusion Criteria:

* Age ≥60 years
* A diagnosis of AML or high or very high risk MDS defined by IPSS-R
* Able to provide informed consent
* Being managed in the inpatient setting
* English-speaking

Exclusion Criteria:

* None

Additional Trial Information

Pilot Trial

Enrollment: 50 patients (estimated)

View More

Trial Locations

All Trial Locations

View all clinical trial locations sorted by state.

New York

University of Rochester Medical Center James P. Wilmot Cancer Center

Rochester, NY

Open and Accepting
Interested in this trial?
  • Call us today 😀 keyboard_arrow_right

    We know how difficult and confusing this process can be. If you are interested in this clinical trial or have questions, you can call us at any time. You can also send us a direct message with questions.

    (888) 828-2206
  • If you are interested in keeping an eye on this trial, you can add it to your list of favorite trials. We'll send you alerts when this trial is updated.

  • Talk to your doctor keyboard_arrow_right

    You can print an overview of this trial to take in to your next appointment. Your doctor can help you understand if this trial may be right for you.

Still need help? Send us a message